Conditions: Colon Cancer; Esophageal Carcinoma; Pancreatic Cancer; Prostate Cancer; Gastric Cancer; Hepatic Carcinoma
Intervention: Biological: CAR-T cell immunotherapy
Sponsor: First Affiliated Hospital of Chengdu Medical College
Recruiting - verified January 2017
http://ift.tt/2jbCJsX
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου